Artiva Biotherapeutics (ARTV) Total Liabilities (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Total Liabilities of $18.1 million for Q1 2026, down 19.45% year-over-year from $22.5 million in Q1 2025, and down 13.65% quarter-over-quarter from $21.0 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Total Liabilities (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Total Liabilities for 4 consecutive years, with $18.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 19.45% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $18.1 million (down 19.45% YoY), while the FY2025 annual figure was $21.0 million, down 8.59% from the prior year.
- Total Liabilities retreated to $18.1 million in Q1 2026 per ARTV's latest filing, from $21.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $50.7 million in Q4 2023 and bottomed at $18.1 million in Q1 2026.
- Historically, Total Liabilities has averaged $27.8 million across 4 years, with a median of $22.5 million in 2025.
- On a YoY basis, Total Liabilities climbed as much as 8.59% in 2025 and fell as far as 59.78% in 2025.
- Artiva Biotherapeutics' Total Liabilities stood at $50.7 million in 2023, then tumbled by 54.77% to $22.9 million in 2024, then retreated by 8.59% to $21.0 million in 2025, then decreased by 13.65% to $18.1 million in 2026.
- Business Quant data shows ARTV's Total Liabilities at $18.1 million in Q1 2026, $21.0 million in Q4 2025, and $19.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 21.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.13 Mn |
| Mar 31, 2026 | 18.11 Mn |
| Dec 31, 2025 | 20.97 Mn |
| Sep 30, 2025 | 19.64 Mn |
| Jun 30, 2025 | 20.35 Mn |
| Mar 31, 2025 | 22.48 Mn |
| Dec 31, 2024 | 22.94 Mn |
| Sep 30, 2024 | 24.60 Mn |
| Jun 30, 2024 | 50.60 Mn |
| Dec 31, 2023 | 50.72 Mn |